Parkinson's Disease - BHV8000-301

Parkinson’s Disease – BHV8000-301

A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson’s disease.

Key Inclusion Criteria:

Male or female participants 40 to 85 years of age, inclusive, at the time of informed consent.
Meet the diagnostic criteria for “Probable PD” as assessed on the Movement Disorder Society (MDS) Clinical Diagnostic Criteria for PD as assessed by the Investigator.
Have a clinician-documented diagnosis of idiopathic PD with an onset within 2 years of the Screening Visit

Complete the form and our team will reach out soon to help determine your eligibility.

View Study on ClinicalTrials.gov

Trial Interest Form

I am a...

First Name(Required)

Last Name(Required)

Location(Required)

Phone(Required)

Email(Required)

Gender

Conditions

Race

Contact Preference

How did you hear about us?

Other (Please specify)

This field is hidden when viewing the form

Trial (Origination Page)

This field is hidden when viewing the form

UTM Source

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Campaign

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

Phone(Required)

Zip Code(Required)

What is the best way to contact you?(Required)

Comments(Required)

Please let us know what's on your mind. Have a question for us? Ask away.

This field is hidden when viewing the form

Origination Page

Parkinson’s Disease – BHV8000-301